PNL-95549-94421
2 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 024 / MA
- Registered
- 2021-11-04
- Relationship
- Child or adolescent in my care
- Guardian
- YA7-12587-14386
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-03
Dose 1 — Pfizer-BioNTech
-
2021-11-04
Registered in v-safe
-
2021-11-04
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-09
- 2021-11-11
- 2021-11-17
-
2021-11-24
Dose 2 — Pfizer-BioNTech
- 2021-11-24
-
2021-11-25
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-11-26
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-11-27
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-28
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-22
- 2021-12-29
-
2022-01-05
Survey response — day 42, dose 2, dependentMedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore throat; runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-05
Report sent to call center — day 42, dose 2, dependentBe unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-24
- 2022-05-25
-
2022-11-24
Survey response — 12 months, dose 2, dependentMedDRA: Nasopharyngitis — Feeling: GoodFree text: A coldMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-03 | Pfizer-BioNTech | No |
| 2 | 2021-11-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-05 | Successful 2022-01-10 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 10 — day 42, dose 2, dependent
Symptoms: Sore throat; runny nose
Release 12 — 12 months, dose 2, dependent
Symptoms: A cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release